3.785USD-1.43%Mkt Cap: 229.90M USDP/E: —Last update: 2026-06-01
Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibod…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap229.90M USD
Enterprise Value126.92M USD
Revenue (TTM)36.49M USD
Gross Profit-88.86M USD
Net Income (TTM)-119.72M USD
Revenue/Share0.6190 USD
Last Price3.785 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees141
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS92915B1061
Valuation
P/E (Trailing)—
P/E (Forward)-2.46
PEG—
EV/EBITDA-1.06
EV/Revenue3.48
P/S6.41
P/B1.17
EPS (TTM)-1.98
EPS (Forward)-1.58
52W Range
2.65039% of range5.550
52W High5.550 USD
52W Low2.650 USD
Profitability
Gross Margin-243.48%
Oper. Margin-1167.37%
EBITDA Margin0.00%
Profit Margin-296.53%
ROE-61.06%
ROA-47.46%
Growth
Revenue Growth-59.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-132.47M USD
CapEx (TTM)2.60M USD
FCF Margin-221.49%
FCF Yield-35.16%
Net Debt-106.91M USD
Net Debt/EBITDA0.89
Balance Sheet
Debt/Equity0.19
Current Ratio8.42
Quick Ratio8.20
Book Value/Sh3.321 USD
Cash/Share2.342 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)14.89 USD
Target Range8.000 USD – 25.00 USD
# Analysts9
Ownership
Shares Out.60.42M
Float44.22M
Insiders15.14%
Institutions56.38%
Short Interest
Short Ratio6.9d
Short % Float6.75%
Short % Out.5.74%
Shares Short3.47M
Short (prev mo.)3.57M
Technical
SMA 503.911 (-3.2%)
SMA 2004.088 (-7.4%)
Beta1.26
S&P 52W Chg27.70%
Avg Vol (30d)502.00K
Avg Vol (10d)640.55K
Technical Indicators
RSI (14)49.2
MACD-0.0401
MACD Signal-0.0457
MACD Hist.+0.0056
BB Upper4.330 USD
BB Middle3.877 USD
BB Lower3.424 USD
BB Width23.37%
ATR (14)0.2234 USD
Vol Ratio (20d)0.60x